Tag Results

Tag Archives: Sloan-Kettering

Listen: Take Note: Ralph Moss on “The Suppression of Laetrile at Sloan-Kettering Institute”

My latest documentary, “Second Opinion: Laetrile At Sloan-Kettering” will be opening up theatrically this summer in as many as 8 cities to start.

Ralph W. Moss, PhD, the hero of this story recently participated in an outstanding interview with NPR affiliate WPSU at Penn State.

CLICK HERE TO LISTEN TO THIS 2-PART INTERVIEW

Summary:
America’s War on Cancer began in the early 1970s and New York’s Memorial Sloan-Kettering Cancer Center was the research institution leading the charge. According to a new book, and documentary, the Center wasn’t always truthful with the American public. When it came to Laetrile Therapy, at the time a widely publicized alternative cancer treatment, our next guest says they lied about its effectiveness and suppressed their own positive test results. Was there a cover-up? And if so, why? Our guest is Ralph Moss, a science writer for more than 40 years. He’s written 10 books and made three documentary films on cancer. His newest book is “Doctored Results: The Suppression of Laetrile at Sloan-Kettering Institute for Cancer Research.” The documentary film, “Second Opinion,” by filmmaker Eric Merola, is based on that book.

Watch the theatrical trailer:

eric-merola-ralph-moss

Q&A from a March 6, 2014 screening of “Second Opinion: Laetrile At Sloan-Kettering” with Ralph W. Moss, PhD & director Eric Merola

“Second Opinion: Laetrile At Sloan-Kettering” had its World Premiere at the San Luis Obispo Film Festival, CA on March 6, 2014. This posting also includes additional clips from the film.

About the film:

“Ralph W. Moss has stayed the course in stating his case.
I am glad his voice is being heard.”
Harold P. Freeman, MD
Past National President, American Cancer Society
Past Chairman, President’s Cancer Panel

The War On Cancer, launched in the early 1970s, set the stage for a massive influx of new ideas in fighting the disease of cancer. Memorial Sloan-Kettering Cancer Center, America’s leading cancer research center at the time, was assigned the task of testing an unconventional therapy called “Laetrile” in an effort to curb the public’s “false hope” in the alleged “quack” therapy.

Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Kettering’s public relations department in 1974 to help brief the American public on the center’s contribution to the War On Cancer. One of his first assignments was to write a biography about Dr. Kanematsu Sugiura, one of the Center’s oldest and leading research scientists as well as the original co-inventor of chemotherapy.

While meeting with this iconic scientist to pen a biography on his 60-year career at
Sloan-Kettering, Moss discovered that Sugiura had been studying this “quack remedy” 
in laboratory mice, and with unexpectedly positive results. Shocked and bewildered, Moss reported back to his superiors what he had discovered, only to be met with backlash and denial from Sloan-Kettering’s leaders on what their own leading scientist had found. 

Fueled by respect and admiration for Sugiura—Ralph W. Moss attempted to publicize 
the truth about Sugiura’s findings. And after all diplomatic approaches failed, Moss lived 
a double life, working as a loyal employee at Sloan-Kettering while also recruiting fellow employees to help anonymously leak this information to the American public—
through a newly formed underground organization they called—“Second Opinion”.

Watch the theatrical trailer: